Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165152 · ClinicalTrials.gov registry record · NA
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT00165152: Completed NA study, sponsored by Dana-Farber Cancer Institute.
NCT00165152 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00165152, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
To evaluate two different ways of providing information about genetic testing for BRCA1 and BRCA2 alterations. The two forms of counseling are genetic counseling and enhanced informed consent which cover similar material but are organized differently.
Interventions
- PROCEDURE Genetic Counseling
- PROCEDURE Informed Consent Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 1998-07 |
| Est. Completion | 2005-06 |
| Phase | NA |
What the finished NCT00165152 record still lists
NCT00165152 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Genetic Counseling is the first listed.
NCT00165152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00165152 about?
NCT00165152 is a clinical study titled "Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing". To evaluate two different ways of providing information about genetic testing for BRCA1 and BRCA2 alterations. The two forms of counseling are genetic counseling and enhanced informed consent which cover similar material but are organized differently.
What is the current status of trial NCT00165152?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 1998-07. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00165152?
The interventions under investigation include: Genetic Counseling (PROCEDURE), Informed Consent Counseling (PROCEDURE).
Who is sponsoring clinical trial NCT00165152?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00165152's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia